Taking a weekly exenatide shot doesn’t lower the chance of eye problems from diabetes, even if your blood sugar improves or you already had early eye issues.

82

Pro

0

Against

Evidence from Studies

Supporting (1)

82

Community contributions welcome

82

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

Randomized Controlled Trial

Human

2020 Feb

The study looked at whether a diabetes drug called once-weekly exenatide helps prevent eye problems, and found it didn’t make a difference compared to a placebo, which supports the claim.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

Score: 82

DOI: 10.2337/dc19-1065

Similar Assertions

A weekly diabetes shot called exenatide doesn’t seem to lower the risk of serious kidney problems in adults with type 2 diabetes when looking at the raw data. But when researchers adjusted the numbers, it showed a small benefit when including a wider range of kidney issues, like high protein in the urine.

82

0

70%

Taking a weekly diabetes shot called exenatide doesn’t seem to lower the risk of a specific type of kidney problem in adults with type 2 diabetes — the numbers don’t show a clear benefit.

82

0

70%